Martin Dahl
Corporate Officer/Principal at ANAPTYSBIO, INC.
Profile
Martin Dahl is currently working as a Senior Vice President-Research at AnaptysBio, Inc. Previously, he worked as the Global Head-Immunology Network at Takeda Pharmaceuticals U.S.A., Inc. Dr. Dahl completed his undergraduate degree at the University of California, Irvine and holds a doctorate degree from the University of Tokyo.
Martin Dahl active positions
Companies | Position | Start |
---|---|---|
ANAPTYSBIO, INC. | Corporate Officer/Principal | 31/12/2017 |
Former positions of Martin Dahl
Companies | Position | End |
---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Training of Martin Dahl
University of California, Irvine | Undergraduate Degree |
University of Tokyo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
Private companies | 1 |
---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
- Stock Market
- Insiders
- Martin Dahl